<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39275259</PMID><DateCompleted><Year>2024</Year><Month>09</Month><Day>14</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2072-6643</ISSN><JournalIssue CitedMedium="Internet"><Volume>16</Volume><Issue>17</Issue><PubDate><Year>2024</Year><Month>Sep</Month><Day>02</Day></PubDate></JournalIssue><Title>Nutrients</Title><ISOAbbreviation>Nutrients</ISOAbbreviation></Journal><ArticleTitle><i>Lactiplantibacillus plantarum</i> P470 Isolated from Fermented Chinese Chives Has the Potential to Improve In Vitro the Intestinal Microbiota and Biological Activity in Feces of Coronary Heart Disease (CHD) Patients.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2945</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/nu16172945</ELocationID><Abstract><AbstractText>Traditional fermented foods are known to offer cardiovascular health benefits. However, the potential of fermented Chinese chives (FCC) in reducing coronary heart disease (CHD) remains unclear. This study employed anaerobic fermentation to investigate <i>Lactiplantibacillus plantarum</i> (<i>L. plantarum</i>) P470 from FCC. The results indicated that <i>L. plantarum</i> P470 enhanced hydroxyl radical scavenging and exhibited anti-inflammatory effects on RAW264.7 macrophages in the fecal fermentation supernatant of CHD patients. These effects were attributed to the modulation of gut microbiota and metabolites, including short-chain fatty acids (SCFAs). Specifically, <i>L. plantarum</i> P470 increased the abundance of <i>Bacteroides</i> and <i>Lactobacillus</i> while decreasing <i>Escherichia-Shigella</i>, <i>Enterobacter</i>, <i>Veillonella</i>, <i>Eggerthella</i>, and <i>Helicobacter</i> in CHD patient fecal samples. Furthermore, <i>L. plantarum</i> P470 regulated the biosynthesis of unsaturated fatty acids and linoleic acid metabolism. These findings suggest that <i>L. plantarum</i> P470 from FCC can improve the fecal physiological status in patients with CHD by modulating intestinal microbiota, promoting SCFA production, and regulating lipid metabolism.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Lingshuang</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0002-1375-4309</Identifier><AffiliationInfo><Affiliation>College of Food Science, South China Agricultural University, Guangzhou 510642, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Health Commission Science and Technology Innovation Platform for Nutrition and Safety of Microbial Food, Guangdong Provincial Key Laboratory of Microbial Safety and Health, State Key Laboratory of Applied Microbiology Southern China, Institute of Microbiology, Guangdong Academy of Sciences, Guangzhou 510070, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Yuwei</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>National Health Commission Science and Technology Innovation Platform for Nutrition and Safety of Microbial Food, Guangdong Provincial Key Laboratory of Microbial Safety and Health, State Key Laboratory of Applied Microbiology Southern China, Institute of Microbiology, Guangdong Academy of Sciences, Guangzhou 510070, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Juan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>The First Affiliated Hospital, School of Clinical Medicine of Guangdong Pharmaceutical University, Guangzhou 510060, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Ying</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0003-4012-6954</Identifier><AffiliationInfo><Affiliation>National Health Commission Science and Technology Innovation Platform for Nutrition and Safety of Microbial Food, Guangdong Provincial Key Laboratory of Microbial Safety and Health, State Key Laboratory of Applied Microbiology Southern China, Institute of Microbiology, Guangdong Academy of Sciences, Guangzhou 510070, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Xinyu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>National Health Commission Science and Technology Innovation Platform for Nutrition and Safety of Microbial Food, Guangdong Provincial Key Laboratory of Microbial Safety and Health, State Key Laboratory of Applied Microbiology Southern China, Institute of Microbiology, Guangdong Academy of Sciences, Guangzhou 510070, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Tingting</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>National Health Commission Science and Technology Innovation Platform for Nutrition and Safety of Microbial Food, Guangdong Provincial Key Laboratory of Microbial Safety and Health, State Key Laboratory of Applied Microbiology Southern China, Institute of Microbiology, Guangdong Academy of Sciences, Guangzhou 510070, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Longyan</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>National Health Commission Science and Technology Innovation Platform for Nutrition and Safety of Microbial Food, Guangdong Provincial Key Laboratory of Microbial Safety and Health, State Key Laboratory of Applied Microbiology Southern China, Institute of Microbiology, Guangdong Academy of Sciences, Guangzhou 510070, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Tong</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>National Health Commission Science and Technology Innovation Platform for Nutrition and Safety of Microbial Food, Guangdong Provincial Key Laboratory of Microbial Safety and Health, State Key Laboratory of Applied Microbiology Southern China, Institute of Microbiology, Guangdong Academy of Sciences, Guangzhou 510070, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Tiantian</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>National Health Commission Science and Technology Innovation Platform for Nutrition and Safety of Microbial Food, Guangdong Provincial Key Laboratory of Microbial Safety and Health, State Key Laboratory of Applied Microbiology Southern China, Institute of Microbiology, Guangdong Academy of Sciences, Guangzhou 510070, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Jumei</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>National Health Commission Science and Technology Innovation Platform for Nutrition and Safety of Microbial Food, Guangdong Provincial Key Laboratory of Microbial Safety and Health, State Key Laboratory of Applied Microbiology Southern China, Institute of Microbiology, Guangdong Academy of Sciences, Guangzhou 510070, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Haojie</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0001-6586-756X</Identifier><AffiliationInfo><Affiliation>The First Affiliated Hospital, School of Clinical Medicine of Guangdong Pharmaceutical University, Guangzhou 510060, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xie</LastName><ForeName>Xinqiang</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0003-3943-7755</Identifier><AffiliationInfo><Affiliation>National Health Commission Science and Technology Innovation Platform for Nutrition and Safety of Microbial Food, Guangdong Provincial Key Laboratory of Microbial Safety and Health, State Key Laboratory of Applied Microbiology Southern China, Institute of Microbiology, Guangdong Academy of Sciences, Guangzhou 510070, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Qingping</ForeName><Initials>Q</Initials><Identifier Source="ORCID">0000-0001-6503-359X</Identifier><AffiliationInfo><Affiliation>College of Food Science, South China Agricultural University, Guangzhou 510642, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>National Health Commission Science and Technology Innovation Platform for Nutrition and Safety of Microbial Food, Guangdong Provincial Key Laboratory of Microbial Safety and Health, State Key Laboratory of Applied Microbiology Southern China, Institute of Microbiology, Guangdong Academy of Sciences, Guangzhou 510070, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2021YFA0910200</GrantID><Agency>Project of National Key Research and Development</Agency><Country /></Grant><Grant><GrantID>2020B121201009</GrantID><Agency>Key Laboratory of Guangdong Province</Agency><Country /></Grant><Grant><GrantID>2020GDASYL-20200103026</GrantID><Agency>the GDAS Special Project of Capacity Building for Innovation-driven Development</Agency><Country /></Grant><Grant><GrantID>2019QN01N107</GrantID><Agency>Project by the Department of Science and Technology of Guangdong Province</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Nutrients</MedlineTA><NlmUniqueID>101521595</NlmUniqueID><ISSNLinking>2072-6643</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005232">Fatty Acids, Volatile</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000069196" MajorTopicYN="Y">Gastrointestinal Microbiome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005243" MajorTopicYN="Y">Feces</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003327" MajorTopicYN="Y">Coronary Disease</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000074421" MajorTopicYN="Y">Fermented Foods</DescriptorName><QualifierName UI="Q000382" MajorTopicYN="N">microbiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D048191" MajorTopicYN="Y">Lactobacillus plantarum</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005232" MajorTopicYN="Y">Fatty Acids, Volatile</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000032" MajorTopicYN="N">analysis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005285" MajorTopicYN="N">Fermentation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000067996" MajorTopicYN="N">RAW 264.7 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019936" MajorTopicYN="N">Probiotics</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="N">pharmacology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Lactiplantibacillus plantarum P470</Keyword><Keyword MajorTopicYN="N">biological activity</Keyword><Keyword MajorTopicYN="N">coronary heart disease (CHD)</Keyword><Keyword MajorTopicYN="N">fermented Chinese chives</Keyword><Keyword MajorTopicYN="N">intestinal microbiota</Keyword></KeywordList><CoiStatement>The authors state that the study was conducted with no commercial advertising or a financial relationship that may be interpreted as potential conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>10</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>14</Day><Hour>1</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39275259</ArticleId><ArticleId IdType="pmc">PMC11397641</ArticleId><ArticleId IdType="doi">10.3390/nu16172945</ArticleId><ArticleId IdType="pii">nu16172945</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mendis S., Davis S., Norrving B. Organizational update: The world health organization global status report on noncommunicable diseases 2014; one more landmark step in the combat against stroke and vascular disease. Stroke. 2015;46:e121–e122. doi: 10.1161/STROKEAHA.115.008097.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/STROKEAHA.115.008097</ArticleId><ArticleId IdType="pubmed">25873596</ArticleId></ArticleIdList></Reference><Reference><Citation>Hansson G.K., Hermansson A. The immune system in atherosclerosis. Nat. Immunol. 2011;12:204–212. doi: 10.1038/ni.2001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2001</ArticleId><ArticleId IdType="pubmed">21321594</ArticleId></ArticleIdList></Reference><Reference><Citation>Ridker P.M. From C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream to Identify Novel Targets for Atheroprotection. Circ. Res. 2016;118:145–156. doi: 10.1161/CIRCRESAHA.115.306656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.115.306656</ArticleId><ArticleId IdType="pmc">PMC4793711</ArticleId><ArticleId IdType="pubmed">26837745</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H., Wang H., Li Q., Wang Y.W., He Y., Li X.J., Sun C.Y., Onder E., Can F.S., Pang Z.Q., et al. LPS adsorption and inflammation alleviation by polymyxin B-modified liposomes for atherosclerosis treatment. Acta Pharm. Sin. B. 2023;13:3817–3833. doi: 10.1016/j.apsb.2023.06.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apsb.2023.06.005</ArticleId><ArticleId IdType="pmc">PMC10501887</ArticleId><ArticleId IdType="pubmed">37719368</ArticleId></ArticleIdList></Reference><Reference><Citation>Almeida S.O., Budoff M. Effect of statins on atherosclerotic plaque. Trends Cardiovasc. Med. 2019;29:451–455. doi: 10.1016/j.tcm.2019.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tcm.2019.01.001</ArticleId><ArticleId IdType="pubmed">30642643</ArticleId></ArticleIdList></Reference><Reference><Citation>Saiyitijiang A., Aizezi M., Zhao Y., Gao Y. Efficacy and safety of new oral anticoagulants combined with antiplatelet drugs in the treatment of coronary heart disease: Systematic evaluation and meta-analysis. Ann. Noninvasive Electrocardiol. 2022;27:e12977. doi: 10.1111/anec.12977.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/anec.12977</ArticleId><ArticleId IdType="pmc">PMC9484016</ArticleId><ArticleId IdType="pubmed">35715952</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S.J., Tsui P.F., Chuang Y.P., Chiang D.M., Chen L.W., Liu S.T., Lin F.Y., Huang S.M., Lin S.H., Wu W.L., et al. Carvedilol Ameliorates Experimental Atherosclerosis by Regulating Cholesterol Efflux and Exosome Functions. Int. J. Mol. Sci. 2019;20:5202. doi: 10.3390/ijms20205202.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20205202</ArticleId><ArticleId IdType="pmc">PMC6834197</ArticleId><ArticleId IdType="pubmed">31635197</ArticleId></ArticleIdList></Reference><Reference><Citation>Padam P., Barton L., Wilson S., David A., Walji S., de Lorenzo F., Ray K.K., Jones B., Cegla J. Lipid lowering with inclisiran: A real-world single-centre experience. Open Heart. 2022;9:e002184. doi: 10.1136/openhrt-2022-002184.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/openhrt-2022-002184</ArticleId><ArticleId IdType="pmc">PMC9748986</ArticleId><ArticleId IdType="pubmed">36600646</ArticleId></ArticleIdList></Reference><Reference><Citation>Karlsson F.H., Fak F., Nookaew I., Tremaroli V., Fagerberg B., Petranovic D., Backhed F., Nielsen J. Symptomatic atherosclerosis is associated with an altered gut metagenome. Nat. Commun. 2012;3:1245. doi: 10.1038/ncomms2266.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms2266</ArticleId><ArticleId IdType="pmc">PMC3538954</ArticleId><ArticleId IdType="pubmed">23212374</ArticleId></ArticleIdList></Reference><Reference><Citation>Jin L., Shi X., Yang J., Zhao Y., Xue L., Xu L., Cai J. Gut microbes in cardiovascular diseases and their potential therapeutic applications. Protein Cell. 2021;12:346–359. doi: 10.1007/s13238-020-00785-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-020-00785-9</ArticleId><ArticleId IdType="pmc">PMC8106559</ArticleId><ArticleId IdType="pubmed">32989686</ArticleId></ArticleIdList></Reference><Reference><Citation>Ditano-Vazquez P., Torres-Pena J.D., Galeano-Valle F., Perez-Caballero A.I., Demelo-Rodriguez P., Lopez-Miranda J., Katsiki N., Delgado-Lista J., Alvarez-Sala-Walther L.A. The Fluid Aspect of the Mediterranean Diet in the Prevention and Management of Cardiovascular Disease and Diabetes: The Role of Polyphenol Content in Moderate Consumption of Wine and Olive Oil. Nutrients. 2019;11:2833. doi: 10.3390/nu11112833.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu11112833</ArticleId><ArticleId IdType="pmc">PMC6893438</ArticleId><ArticleId IdType="pubmed">31752333</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang H.Y., Yang S.C., Chao J.C., Chen J.R. Beneficial effects of catechin-rich green tea and inulin on the body composition of overweight adults. Br. J. Nutr. 2012;107:749–754. doi: 10.1017/S0007114511005095.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0007114511005095</ArticleId><ArticleId IdType="pubmed">22032343</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamadshahi M., Veissi M., Haidari F., Shahbazian H., Kaydani G.A., Mohammadi F. Effects of probiotic yogurt consumption on inflammatory biomarkers in patients with type 2 diabetes. Bioimpacts. 2014;4:83–88.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4097976</ArticleId><ArticleId IdType="pubmed">25035851</ArticleId></ArticleIdList></Reference><Reference><Citation>Mokoena M.P., Mutanda T., Olaniran A.O. Perspectives on the probiotic potential of lactic acid bacteria from African traditional fermented foods and beverages. Food Nutr. Res. 2016;60:29630. doi: 10.3402/fnr.v60.29630.</Citation><ArticleIdList><ArticleId IdType="doi">10.3402/fnr.v60.29630</ArticleId><ArticleId IdType="pmc">PMC4785221</ArticleId><ArticleId IdType="pubmed">26960543</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J., Ji Y., Park H., Lee J., Park S., Yeo S., Shin H., Holzapfel W.H. Selection of functional lactic acid bacteria as starter cultures for the fermentation of Korean leek (Allium tuberosum Rottler ex Sprengel.) Int. J. Food Microbiol. 2014;191:164–171. doi: 10.1016/j.ijfoodmicro.2014.09.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijfoodmicro.2014.09.016</ArticleId><ArticleId IdType="pubmed">25279760</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar R., Grover S., Batish V.K. Hypocholesterolaemic effect of dietary inclusion of two putative probiotic bile salt hydrolase-producing Lactobacillus plantarum strains in Sprague-Dawley rats. Br. J. Nutr. 2011;105:561–573. doi: 10.1017/S0007114510003740.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0007114510003740</ArticleId><ArticleId IdType="pubmed">20923582</ArticleId></ArticleIdList></Reference><Reference><Citation>Jeun J., Kim S., Cho S.Y., Jun H.J., Park H.J., Seo J.G., Chung M.J., Lee S.J. Hypocholesterolemic effects of Lactobacillus plantarum KCTC3928 by increased bile acid excretion in C57BL/6 mice. Nutrition. 2010;26:321–330.</Citation><ArticleIdList><ArticleId IdType="pubmed">19695834</ArticleId></ArticleIdList></Reference><Reference><Citation>Song D.F., Zhu M.Y., Gu Q. Purification and characterization of Plantaricin ZJ5, a new bacteriocin produced by Lactobacillus plantarum ZJ5. PLoS ONE. 2014;9:e105549. doi: 10.1371/journal.pone.0105549.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0105549</ArticleId><ArticleId IdType="pmc">PMC4141769</ArticleId><ArticleId IdType="pubmed">25147943</ArticleId></ArticleIdList></Reference><Reference><Citation>Mo S.J., Lee K., Hong H.J., Hong D.K., Jung S.H., Park S.D., Shim J.J., Lee J.L. Effects of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 on Overweight and the Gut Microbiota in Humans: Randomized, Double-Blinded, Placebo-Controlled Clinical Trial. Nutrients. 2022;14:2484. doi: 10.3390/nu14122484.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14122484</ArticleId><ArticleId IdType="pmc">PMC9228474</ArticleId><ArticleId IdType="pubmed">35745214</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao H., Zhang X., Tong L., Liu Q., Liang X., Bu Y., Gong P., Liu T., Zhang L., Xia Y., et al. Effect of Extracellular Vesicles Derived From Lactobacillus plantarum Q7 on Gut Microbiota and Ulcerative Colitis in Mice. Front. Immunol. 2021;12:777147. doi: 10.3389/fimmu.2021.777147.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2021.777147</ArticleId><ArticleId IdType="pmc">PMC8674835</ArticleId><ArticleId IdType="pubmed">34925349</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu R., Fang Y., Li H., Liu Y., Wei J., Zhang S., Wang L., Fan R., Wang L., Li S., et al. Psychobiotic Lactobacillus plantarum JYLP-326 relieves anxiety, depression, and insomnia symptoms in test anxious college via modulating the gut microbiota and its metabolism. Front. Immunol. 2023;14:1158137. doi: 10.3389/fimmu.2023.1158137.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1158137</ArticleId><ArticleId IdType="pmc">PMC10077425</ArticleId><ArticleId IdType="pubmed">37033942</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu L., Tao X., Xiong H., Yu J., Wei H. Lactobacillus plantarum ZDY04 exhibits a strain-specific property of lowering TMAO via the modulation of gut microbiota in mice. Food Funct. 2018;9:4299–4309. doi: 10.1039/C8FO00349A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/C8FO00349A</ArticleId><ArticleId IdType="pubmed">30039147</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen G., Wang M., Zeng Z., Xie M., Xu W., Peng Y., Zhou W., Sun Y., Zeng X., Liu Z. Fuzhuan brick tea polysaccharides serve as a promising candidate for remodeling the gut microbiota from colitis subjects in vitro: Fermentation characteristic and anti-inflammatory activity. Food Chem. 2022;391:133203. doi: 10.1016/j.foodchem.2022.133203.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.foodchem.2022.133203</ArticleId><ArticleId IdType="pubmed">35597036</ArticleId></ArticleIdList></Reference><Reference><Citation>Hara K., Someya T., Sano K., Sagane Y., Watanabe T., Wijesekara R.G.S. Antioxidant activities of traditional plants in Sri Lanka by DPPH free radical-scavenging assay. Data Brief. 2018;17:870–875. doi: 10.1016/j.dib.2018.02.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dib.2018.02.013</ArticleId><ArticleId IdType="pmc">PMC5834651</ArticleId><ArticleId IdType="pubmed">29516033</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen H., Li Y., Xie X., Chen M., Xue L., Wang J., Ye Q., Wu S., Yang R., Zhao H., et al. Exploration of the Molecular Mechanisms Underlying the Anti-Photoaging Effect of Limosilactobacillus fermentum XJC60. Front. Cell Infect. Microbiol. 2022;12:838060. doi: 10.3389/fcimb.2022.838060.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2022.838060</ArticleId><ArticleId IdType="pmc">PMC9104571</ArticleId><ArticleId IdType="pubmed">35573770</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang L., Xie X., Li Y., Wu L., Fan C., Liang T., Xi Y., Yang S., Li H., Zhang J., et al. Evaluation of the Cholesterol-Lowering Mechanism of Enterococcus faecium Strain 132 and Lactobacillus paracasei Strain 201 in Hypercholesterolemia Rats. Nutrients. 2021;13:1982. doi: 10.3390/nu13061982.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu13061982</ArticleId><ArticleId IdType="pmc">PMC8228983</ArticleId><ArticleId IdType="pubmed">34207558</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Cao Y., Lu R., Li H., Pang Y., Fu H., Fang G., Chen Q., Liu B., Wu J., et al. Integrated Fecal Microbiome and Serum Metabolomics Analysis Reveals Abnormal Changes in Rats with Immunoglobulin A Nephropathy and the Intervention Effect of Zhen Wu Tang. Front. Pharmacol. 2020;11:606689.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7872959</ArticleId><ArticleId IdType="pubmed">33584283</ArticleId></ArticleIdList></Reference><Reference><Citation>Blaak E.E., Canfora E.E., Theis S., Frost G., Groen A.K., Mithieux G., Nauta A., Scott K., Stahl B., van Harsselaar J., et al. Short chain fatty acids in human gut and metabolic health. Benef. Microbes. 2020;11:411–455. doi: 10.3920/BM2020.0057.</Citation><ArticleIdList><ArticleId IdType="doi">10.3920/BM2020.0057</ArticleId><ArticleId IdType="pubmed">32865024</ArticleId></ArticleIdList></Reference><Reference><Citation>Low Wang C.C., Hess C.N., Hiatt W.R., Goldfine A.B. Clinical Update: Cardiovascular Disease in Diabetes Mellitus: Atherosclerotic Cardiovascular Disease and Heart Failure in Type 2 Diabetes Mellitus-Mechanisms, Management, and Clinical Considerations. Circulation. 2016;133:2459–2502. doi: 10.1161/CIRCULATIONAHA.116.022194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.116.022194</ArticleId><ArticleId IdType="pmc">PMC4910510</ArticleId><ArticleId IdType="pubmed">27297342</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown J.M., Hazen S.L. The gut microbial endocrine organ: Bacterially derived signals driving cardiometabolic diseases. Annu. Rev. Med. 2015;66:343–359. doi: 10.1146/annurev-med-060513-093205.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-med-060513-093205</ArticleId><ArticleId IdType="pmc">PMC4456003</ArticleId><ArticleId IdType="pubmed">25587655</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanders M.E., Merenstein D.J., Reid G., Gibson G.R., Rastall R.A. Probiotics and prebiotics in intestinal health and disease: From biology to the clinic. Nat. Rev. Gastroenterol. Hepatol. 2019;16:605–616. doi: 10.1038/s41575-019-0173-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41575-019-0173-3</ArticleId><ArticleId IdType="pubmed">31296969</ArticleId></ArticleIdList></Reference><Reference><Citation>Leeuwendaal N.K., Stanton C., O’Toole P.W., Beresford T.P. Fermented Foods, Health and the Gut Microbiome. Nutrients. 2022;14:1527. doi: 10.3390/nu14071527.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14071527</ArticleId><ArticleId IdType="pmc">PMC9003261</ArticleId><ArticleId IdType="pubmed">35406140</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu R., Shang N., Li P. In vitro and in vivo antioxidant activity of exopolysaccharide fractions from Bifidobacterium animalis RH. Anaerobe. 2011;17:226–231. doi: 10.1016/j.anaerobe.2011.07.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.anaerobe.2011.07.010</ArticleId><ArticleId IdType="pubmed">21875680</ArticleId></ArticleIdList></Reference><Reference><Citation>Linton M.F., Moslehi J.J., Babaev V.R. Akt Signaling in Macrophage Polarization, Survival, and Atherosclerosis. Int. J. Mol. Sci. 2019;20:2703. doi: 10.3390/ijms20112703.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms20112703</ArticleId><ArticleId IdType="pmc">PMC6600269</ArticleId><ArticleId IdType="pubmed">31159424</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu S., Zhao W., Liu X., Cheng L. Metagenomic analysis of the gut microbiome in atherosclerosis patients identify cross-cohort microbial signatures and potential therapeutic target. FASEB J. 2020;34:14166–14181. doi: 10.1096/fj.202000622R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.202000622R</ArticleId><ArticleId IdType="pubmed">32939880</ArticleId></ArticleIdList></Reference><Reference><Citation>Emoto T., Yamashita T., Sasaki N., Hirota Y., Hayashi T., So A., Kasahara K., Yodoi K., Matsumoto T., Mizoguchi T., et al. Analysis of Gut Microbiota in Coronary Artery Disease Patients: A Possible Link between Gut Microbiota and Coronary Artery Disease. J. Atheroscler. Thromb. 2016;23:908–921. doi: 10.5551/jat.32672.</Citation><ArticleIdList><ArticleId IdType="doi">10.5551/jat.32672</ArticleId><ArticleId IdType="pmc">PMC7399299</ArticleId><ArticleId IdType="pubmed">26947598</ArticleId></ArticleIdList></Reference><Reference><Citation>Manco M., Putignani L., Bottazzo G.F. Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk. Endocr. Rev. 2010;31:817–844. doi: 10.1210/er.2009-0030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/er.2009-0030</ArticleId><ArticleId IdType="pubmed">20592272</ArticleId></ArticleIdList></Reference><Reference><Citation>Alard J., Lehrter V., Rhimi M., Mangin I., Peucelle V., Abraham A.L., Mariadassou M., Maguin E., Waligora-Dupriet A.J., Pot B., et al. Beneficial metabolic effects of selected probiotics on diet-induced obesity and insulin resistance in mice are associated with improvement of dysbiotic gut microbiota. Environ. Microbiol. 2016;18:1484–1497. doi: 10.1111/1462-2920.13181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1462-2920.13181</ArticleId><ArticleId IdType="pubmed">26689997</ArticleId></ArticleIdList></Reference><Reference><Citation>Boo T.W., Cryan B., O’Donnell A., Fahy G. Prosthetic valve endocarditis caused by Veillonella parvula. J. Infect. 2005;50:81–83. doi: 10.1016/j.jinf.2003.11.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2003.11.008</ArticleId><ArticleId IdType="pubmed">15603847</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander M., Ang Q.Y., Nayak R.R., Bustion A.E., Sandy M., Zhang B., Upadhyay V., Pollard K.S., Lynch S.V., Turnbaugh P.J. Human gut bacterial metabolism drives Th17 activation and colitis. Cell Host Microbe. 2022;30:17–30.e19. doi: 10.1016/j.chom.2021.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2021.11.001</ArticleId><ArticleId IdType="pmc">PMC8785648</ArticleId><ArticleId IdType="pubmed">34822777</ArticleId></ArticleIdList></Reference><Reference><Citation>Eicher T.P., Mohajeri M.H. Overlapping Mechanisms of Action of Brain-Active Bacteria and Bacterial Metabolites in the Pathogenesis of Common Brain Diseases. Nutrients. 2022;14:2661. doi: 10.3390/nu14132661.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu14132661</ArticleId><ArticleId IdType="pmc">PMC9267981</ArticleId><ArticleId IdType="pubmed">35807841</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J., Li Y., Ivey K.L., Wang D.D., Wilkinson J.E., Franke A., Lee K.H., Chan A., Huttenhower C., Hu F.B., et al. Interplay between diet and gut microbiome, and circulating concentrations of trimethylamine N-oxide: Findings from a longitudinal cohort of US men. Gut. 2022;71:724–733. doi: 10.1136/gutjnl-2020-322473.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/gutjnl-2020-322473</ArticleId><ArticleId IdType="pmc">PMC8553812</ArticleId><ArticleId IdType="pubmed">33926968</ArticleId></ArticleIdList></Reference><Reference><Citation>Jie Z., Xia H., Zhong S.L., Feng Q., Li S., Liang S., Zhong H., Liu Z., Gao Y., Zhao H., et al. The gut microbiome in atherosclerotic cardiovascular disease. Nat. Commun. 2017;8:845. doi: 10.1038/s41467-017-00900-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00900-1</ArticleId><ArticleId IdType="pmc">PMC5635030</ArticleId><ArticleId IdType="pubmed">29018189</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang L., Shi M., Ji J., Hu X., Chen F. Gut microbiota determines the prevention effects of Luffa cylindrica (L.) Roem supplementation against obesity and associated metabolic disorders induced by high-fat diet. FASEB J. 2019;33:10339–10352. doi: 10.1096/fj.201900488R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201900488R</ArticleId><ArticleId IdType="pubmed">31211921</ArticleId></ArticleIdList></Reference><Reference><Citation>Romano K.A., Vivas E.I., Amador-Noguez D., Rey F.E. Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxide. mBio. 2015;6:e02481. doi: 10.1128/mBio.02481-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mBio.02481-14</ArticleId><ArticleId IdType="pmc">PMC4453578</ArticleId><ArticleId IdType="pubmed">25784704</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi H., Li Y., Dong C., Si G., Xu Y., Peng M., Li Y. Helicobacter pylori infection and the progression of atherosclerosis: A systematic review and meta-analysis. Helicobacter. 2022;27:e12865. doi: 10.1111/hel.12865.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/hel.12865</ArticleId><ArticleId IdType="pubmed">34841620</ArticleId></ArticleIdList></Reference><Reference><Citation>Morrison D.J., Preston T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes. 2016;7:189–200. doi: 10.1080/19490976.2015.1134082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/19490976.2015.1134082</ArticleId><ArticleId IdType="pmc">PMC4939913</ArticleId><ArticleId IdType="pubmed">26963409</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin L., Zhang J. Role of intestinal microbiota and metabolites on gut homeostasis and human diseases. BMC Immunol. 2017;18:2. doi: 10.1186/s12865-016-0187-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12865-016-0187-3</ArticleId><ArticleId IdType="pmc">PMC5219689</ArticleId><ArticleId IdType="pubmed">28061847</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox M.A., Jackson J., Stanton M., Rojas-Triana A., Bober L., Laverty M., Yang X., Zhu F., Liu J., Wang S., et al. Short-chain fatty acids act as antiinflammatory mediators by regulating prostaglandin E2 and cytokines. World J. Gastroenterol. 2009;15:5549–5557. doi: 10.3748/wjg.15.5549.</Citation><ArticleIdList><ArticleId IdType="doi">10.3748/wjg.15.5549</ArticleId><ArticleId IdType="pmc">PMC2785057</ArticleId><ArticleId IdType="pubmed">19938193</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguilar E.C., dos Santos L.C., Leonel A.J., de Oliveira J.S., Santos E.A., Navia-Pelaez J.M., da Silva J.F., Mendes B.P., Capettini L.S.A., Teixeira L.G., et al. Oral butyrate reduces oxidative stress in atherosclerotic lesion sites by a mechanism involving NADPH oxidase down-regulation in endothelial cells. J. Nutr. Biochem. 2016;34:99–105. doi: 10.1016/j.jnutbio.2016.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jnutbio.2016.05.002</ArticleId><ArticleId IdType="pubmed">27261536</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu J.N., Taki F., Sugiyama S., Asai J., Izawa Y., Satake T., Ozawa T. Neutrophil-derived epoxide, 9,10-epoxy-12-octadecenoate, induces pulmonary edema. Lung. 1988;166:327–337.</Citation><ArticleIdList><ArticleId IdType="pubmed">3148792</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugiyama S., Hayakawa M., Nagai S., Ajioka M., Ozawa T. Leukotoxin, 9, 10-epoxy-12-octadecenoate, causes cardiac failure in dogs. Life Sci. 1987;40:225–231. doi: 10.1016/0024-3205(87)90336-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0024-3205(87)90336-5</ArticleId><ArticleId IdType="pubmed">3796222</ArticleId></ArticleIdList></Reference><Reference><Citation>Toomey S., Harhen B., Roche H.M., Fitzgerald D., Belton O. Profound resolution of early atherosclerosis with conjugated linoleic acid. Atherosclerosis. 2006;187:40–49. doi: 10.1016/j.atherosclerosis.2005.08.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.atherosclerosis.2005.08.024</ArticleId><ArticleId IdType="pubmed">16182300</ArticleId></ArticleIdList></Reference><Reference><Citation>Toomey S., Roche H., Fitzgerald D., Belton O. Regression of pre-established atherosclerosis in the apoE−/− mouse by conjugated linoleic acid. Biochem. Soc. Trans. 2003;31:1075–1079. doi: 10.1042/bst0311075.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/bst0311075</ArticleId><ArticleId IdType="pubmed">14505483</ArticleId></ArticleIdList></Reference><Reference><Citation>Stachowska E., Siennicka A., Baskiewcz-Halasa M., Bober J., Machalinski B., Chlubek D. Conjugated linoleic acid isomers may diminish human macrophages adhesion to endothelial surface. Int. J. Food Sci. Nutr. 2012;63:30–35. doi: 10.3109/09637486.2011.593505.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/09637486.2011.593505</ArticleId><ArticleId IdType="pubmed">21721848</ArticleId></ArticleIdList></Reference><Reference><Citation>Vahmani P., Meadus W.J., Duff P., Rolland D.C., Dugan M.E.R. Comparing the lipogenic and cholesterolgenic effects of individual trans-18:1 isomers in liver cells. Eur. J. Lipid Sci. Technol. 2016;119:1600162. doi: 10.1002/ejlt.201600162.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ejlt.201600162</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>